{{Rsnum
|rsid=769224
|Gene=COMT
|Chromosome=22
|position=19964281
|Orientation=plus
|GMAF=0.04729
|Gene_s=COMT,MIR4761
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 0.7 | 13.9 | 85.4
| JPT | 0.9 | 7.1 | 92.0
| YRI | 0.7 | 22.4 | 76.9
| ASW | 0.0 | 21.1 | 78.9
| CHB | 0.7 | 13.9 | 85.4
| CHD | 0.9 | 12.8 | 86.2
| GIH | 0.0 | 6.9 | 93.1
| LWK | 0.0 | 20.0 | 80.0
| MEX | 0.0 | 8.6 | 91.4
| MKK | 0.0 | 5.1 | 94.9
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19365560
|Title=Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs
|OA=1
}}

{{PMID|18574484|OA=1
}} The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase.

{{PMID|21680027}} Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.

{{PMID Auto
|PMID=24174958
|Title=Mercury Promotes Catecholamines Which Potentiate Mercurial Autoimmunity and Vasodilation: Implications for Inositol 1,4,5-Triphosphate 3-Kinase C Susceptibility in Kawasaki Syndrome
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}